DRI Healthcare Trust (TSE:DHT.UN) Price Target Raised to C$26.00

DRI Healthcare Trust (TSE:DHT.UN) had its price target boosted by Stifel Nicolaus from C$25.00 to C$26.00 in a research note published on Tuesday,BayStreet.CA reports. They currently have a buy rating on the stock.

Several other research analysts have also recently issued reports on DHT.UN. Raymond James Financial increased their price objective on DRI Healthcare Trust from C$22.50 to C$23.50 and gave the stock a “strong-buy” rating in a research note on Monday, June 29th. Scotiabank lifted their target price on DRI Healthcare Trust from C$25.00 to C$30.00 and gave the company a “sector outperform” rating in a research report on Tuesday, May 19th. National Bank Financial lifted their target price on DRI Healthcare Trust from C$22.50 to C$23.50 and gave the company an “outperform” rating in a research report on Tuesday, May 19th. Finally, Canaccord Genuity Group upped their target price on DRI Healthcare Trust from C$22.25 to C$23.00 and gave the stock a “buy” rating in a report on Tuesday, June 30th. One analyst has rated the stock with a Strong Buy rating and four have given a Buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of C$25.20.

DRI Healthcare Trust Stock Performance

Shares of TSE:DHT.UN opened at C$18.23 on Tuesday. The firm has a market cap of C$1.00 billion, a PE ratio of -22.79 and a beta of 0.35. The firm’s 50 day simple moving average is C$18.08 and its 200-day simple moving average is C$17.11. DRI Healthcare Trust has a one year low of C$13.90 and a one year high of C$19.75.

DRI Healthcare Trust Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, July 20th. Stockholders of record on Monday, July 20th were issued a $0.11 dividend. The ex-dividend date was Tuesday, June 30th. This represents a $0.44 annualized dividend and a dividend yield of 2.4%. DRI Healthcare Trust’s payout ratio is currently -52.50%.

DRI Healthcare Trust Company Profile

DRI Healthcare Trust is managed by DRI Capital Inc DRI a pioneer in global pharmaceutical royalty monetization. We provide uniquely favorable exposure for investors in the biopharma industry managing a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world and aiming to acquire dependable patent-protected cash flow streams derived from the sales of those important drugs while limiting the risks and costs connected to drug development. DRI has developed a disciplined strategy predicated on actively sourcing royalty streams on medically necessary products and proudly work with multiple repeat deal partners.DRI Healthcare Trust is an unincorporated open-ended trust governed by the laws of the Province of Ontario pursuant to a declaration of trust dated October 21 2020 as amended.DRI Healthcare Trusts units are listed and trade on the Toronto Stock Exchange under DHT.UN in Canadian dollars and under DHT.U in U.S.